A detailed history of Bessemer Group Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Bessemer Group Inc holds 167 shares of TAK stock, worth $2,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167
Previous 167 -0.0%
Holding current value
$2,324
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$15.03 - $16.32 $15,781 - $17,136
-1,050 Reduced 86.28%
167 $3,000
Q2 2023

Aug 10, 2023

BUY
$15.57 - $17.11 $16,348 - $17,965
1,050 Added 628.74%
1,217 $19,000
Q4 2022

Feb 13, 2023

SELL
$12.42 - $15.62 $18,145 - $22,820
-1,461 Reduced 89.74%
167 $3,000
Q3 2022

Nov 09, 2022

BUY
$12.8 - $28.65 $18,700 - $41,857
1,461 Added 874.85%
1,628 $21,000
Q2 2022

Aug 10, 2022

SELL
$13.12 - $15.03 $42,285 - $48,441
-3,223 Reduced 95.07%
167 $2,000
Q1 2022

May 12, 2022

SELL
$13.54 - $15.35 $7,866 - $8,918
-581 Reduced 14.63%
3,390 $49,000
Q4 2021

Jan 27, 2022

BUY
$13.17 - $16.4 $2,989 - $3,722
227 Added 6.06%
3,971 $54,000
Q3 2021

Nov 12, 2021

SELL
$16.3 - $17.26 $3,194 - $3,382
-196 Reduced 4.97%
3,744 $61,000
Q2 2021

Aug 06, 2021

BUY
$16.55 - $18.64 $9,102 - $10,252
550 Added 16.22%
3,940 $66,000
Q1 2021

May 13, 2021

BUY
$16.71 - $19.9 $56,646 - $67,461
3,390 New
3,390 $61,000
Q4 2020

Feb 09, 2021

SELL
$15.39 - $18.97 $5,725 - $7,056
-372 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$17.1 - $19.19 $6,361 - $7,138
372 New
372 $7,000
Q4 2019

Feb 04, 2020

SELL
$16.88 - $20.83 $1,282 - $1,583
-76 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$16.15 - $17.99 $500 - $557
31 Added 68.89%
76 $1,000
Q2 2019

Jul 19, 2019

SELL
$16.58 - $20.49 $5,836 - $7,212
-352 Reduced 88.66%
45 $1,000
Q1 2019

May 13, 2019

BUY
$16.7 - $21.52 $6,629 - $8,543
397 New
397 $8,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.